• Leonid Roshkovan, Jeffrey C Thompson, Neil Chatterjee, Maya Galperin-Aizenberg, and Sharyn I Katz.
• Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. Electronic address: leonid.roshkovan@pennmedicine.upenn.edu.
• Chest. 2021 Feb 1; 159 (2): e107e113e107-e113.

AbstractA 53-year-old man presented to the ED at a time of low severe acute respiratory syndrome coronavirus 2, also known as coronavirus disease 2019 (COVID-19), prevalence and reported 2 weeks of progressive shortness of breath, dry cough, headache, myalgias, diarrhea, and recurrent low-grade fevers to 39°C for 1 week with several days of recorded peripheral capillary oxygen saturation of 80% to 90% (room air) on home pulse oximeter. Five days earlier, he had visited an urgent care center where a routine respiratory viral panel was reportedly negative. A COVID-19 reverse transcriptase polymerase chain reaction test result was pending at the time of ED visit. He reported a past medical history of gastroesophageal reflux disease that was treated with famotidine. Travel history included an out-of-state trip 3 weeks earlier, but no recent international travel.Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

58 keywords...

hide…